Biological Information
Background Information:
The Path Hunter mFcyRIIb clustering cell line is a stable, engineered cell line designed to increase signal produced from a Checkpoint Cell Line via antibody-mediated crosslinking of the receptors. This product is a companion product used to determine cross-linking based increases in potency of agonist antibodies. The cell line included overexpresses mFcyRIIb Fcg receptor. When co-cultured with a Checkpoint Cell Line in the presence of agonist antibody, the Fcg receptor binds to the antibody, inducing receptor clustering. The induced receptor clustering leads to increased activation and downstream signaling, leading to increased EFC signal production.
This stable engineered cell line is provided as two vials of cryopreserved cells. Please note that this product expresses the Mouse version of this protein.
Target Class:
Checkpoint Receptor
Family:
IgSF
Sub Family:
Immunoglobulin Fc Receptor
Protein Name:
FcgR2B
Protein Aliases:
Fc gamma receptor IIB (Fc-gamma RII|Fc-gamma-RIIB| FcRII)|IgG Fc receptor II beta|Lymphocyte antigen 17 (Ly-17)|CD32
Accession Number:
NM_001077189.1
UniProt Number:
P08101
Gene Name:
Fcgr2b
Gene ID:
14130
Gene Aliases:
CD32|Fcgr2|Fcr-2|Fcr-3|Ly-17|LyM-1|Lym-1|fcRII|FcgRII|Fcgr2a|Ly-m20|Fc[g]RII|F630109E10Rik
Target Species:
Mouse
Cell Background:
U2OS
Usage
Product Type:
Stable Cell Lines
Application:
Drug Discovery & Development
Storage Conditions:
Store in vapor phase of liquid nitrogen.
Usage disclaimer:
These products may be covered by issued US and/or foreign patents, patent applications and subject to a Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information.
Assay Information
Assay Type:
Cell Based
Assay Measures:
Clustering
Detection Method:
Chemiluminescence
Clinical Relevance
Therapeutic Area:
Oncology/Immuno-Oncology
Additional Information
Brand:
PathHunter®